Resultados de la búsqueda 141-150 of 12739 for Two-phase

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... phase 2 dose (RP2D) of APG-2575. Understanding the Relationship Between Benign Breast Tissue, Benign Breast Disease, and Breast Cancer Development.

2. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

   This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor ...

3. Clínica de las mamas - Ensayos clínicos

   This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of ...

5. Oncología (médica) - Ensayos clínicos

   ... phase 2 dose (RP2D) of APG-2575. Understanding the Relationship Between Benign Breast Tissue, Benign Breast Disease, and Breast Cancer Development.

6. Hematología - Ensayos clínicos

   ... phase II dose (RP2D of APG2575 in combination ... Patients will be randomized 1:1 into the two arms. ... 2-6: 500 mg/m2). Patients randomized to B+R will ...

7. Oncología (médica) - Ensayos clínicos

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... phase 2 dose (RP2D) of APG-2575. Understanding the Relationship Between Benign Breast Tissue, Benign Breast Disease, and Breast Cancer Development.

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... phase 2 dose (RP2D) of APG-2575. Understanding the Relationship Between Benign Breast Tissue, Benign Breast Disease, and Breast Cancer Development.

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... phase 2 dose (RP2D) of APG-2575. Understanding the Relationship Between Benign Breast Tissue, Benign Breast Disease, and Breast Cancer Development.